Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M812Revenue $M262Net Margin (%)-4.9Z-Score15.0
Enterprise Value $M711EPS $-0.4Operating Margin %-4.5F-Score4
P/E(ttm))0Cash Flow Per Share $0.5Pre-tax Margin (%)-4.7Higher ROA y-yN
Price/Book5.910-y EBITDA Growth Rate %0Quick Ratio4.5Cash flow > EarningsY
Price/Sales3.05-y EBITDA Growth Rate %0Current Ratio4.5Lower Leverage y-yY
Price/Cash Flow54.0y-y EBITDA Growth Rate %-197.4ROA % (ttm)-7.2Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-8.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M31.2ROI % (ttm)1.3Gross Margin Increase y-yN

Gurus Latest Trades with GHDX

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GHDXGeorge Soros 2006-12-31 Sold Out -0.23%$13.85 - $23.89
($17.5)
$ 25.9848%Sold Out0
GHDXGeorge Soros 2006-09-30 Buy 0.23%$11.16 - $14.38
($13)
$ 25.98100%New holding, 236371 sh.236,371
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GHDX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


GHDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Popovits Kimberly JPresident and CEO 2014-07-14Sell3,000$26.590.53 view
Cole G BradleyCOO 2014-07-08Sell2,300$27.05-1.18 view
Shak StevenEVP of R&D 2014-07-01Sell7,000$27-1 view
Popovits Kimberly JPresident and CEO 2014-06-12Sell3,000$26.12.41 view
Shak StevenEVP of R&D 2014-06-12Sell7,000$26.730 view
Schorno Dean LCFO 2014-06-10Sell4,000$27.62-3.22 view
Cole G BradleyCOO 2014-06-09Sell2,337$27.29-2.05 view
Popovits Kimberly JPresident and CEO 2014-05-12Sell3,000$26.540.72 view
Schorno Dean LCFO 2014-05-09Sell4,000$25.096.54 view
Shak StevenEVP of R&D 2014-04-14Sell7,000$26.251.83 view

Press Releases about GHDX :

    Quarterly/Annual Reports about GHDX:

    News about GHDX:

    Articles On GuruFocus.com
    CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares Jul 13 2012 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Mar 16 2011 
    Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Mar 16 2011 
    Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Mar 14 2011 
    Genomic Health Inc. (GHDX) COO G Bradley Cole sells 2,500 Shares Mar 10 2011 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
    Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Feb 16 2011 
    Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Feb 14 2011 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Jan 19 2011 

    More From Other Websites
    3 Health Care Stocks Primed For Big Moves Jul 14 2014
    Show of support for Genomic Health Jul 10 2014
    Genomic Grows on Breast Cancer Test, Margin Pressure Continues Jul 03 2014
    GENOMIC HEALTH INC Files SEC form 8-K, Change in Directors or Principal Officers Jun 19 2014
    Genomic Health's Oncotype DX Redefines Breast Cancer Therapy Jun 12 2014
    Genomic Health Announces Positive Topline Results of Second Large, Independent Validation Study of... Jun 11 2014
    GENOMIC HEALTH INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders Jun 10 2014
    Multiple studies presented at 2014 ASCO® annual meeting reinforce unique, practice-changing value... Jun 10 2014
    Genomic Health Up on Fresh Cancer Study Data Jun 05 2014
    Genomic Health Demonstrates the Importance of Utilizing Multiple Biological Pathways to Predict... Jun 03 2014
    Multiple Studies Presented at ASCO® Annual Meeting Demonstrate Unique, Practice-Changing Impact of... Jun 01 2014
    Genomic Health Posts Fresh Oncotype DX Data May 30 2014
    Oncotype DX® Breast Cancer Test Predicts Late Recurrence Five to 15 Years Out May 29 2014
    Genomic Health to Present at Two Upcoming Investor Conferences May 23 2014
    Genomic Health: Study Boosts Oncotype DX Again May 21 2014
    Genomic Health announces data reinforcing robustness of Oncotype DX May 20 2014
    Genomic Health Announces Data Reinforcing Robustness of Oncotype DX® Prostate Cancer Test at 2014... May 20 2014
    Genomic Health Presents New Oncotype DX Data May 19 2014
    Genomic Health says studies show test predicts prostate cancer aggressiveness May 16 2014
    European Urology Published Groundbreaking Results from Three Studies Demonstrating Genomic Health's... May 16 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide